Companies › NVCR

NOVOCURE LTD (NVCR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001645113 · EDGAR filings · Updated 2026-07-23

NOVOCURE LTD (NVCR) has reported institutional ownership of 84.9%, with 222 institutional managers holding positions valued at $1.08B per the latest 13F reporting period. SEC filings include an active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Filings this week (3)

• 2026-07-23 — Notice of proposed sale filed (Form 144)
• 2026-07-23 — Current report (8-K) filed
• 2026-07-23 — Quarterly report (10-Q) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-01 — Insider transaction reported (Form 4)
• 2026-07-01 — Insider transaction reported (Form 4)
• 2026-07-01 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NOVOCURE LTD has 222 institutional holders and institutional ownership of 84.9%.

Insider activity

Insiders reported 71 transactions (4 buys, 29 sells) across 18 reporting insiders, with a net reported value of −$1.76M.

Data flags from SEC filings

Related companies

SEPTERNA INC (SEPN) · ZENAS BIOPHARMA INC (ZBIO) · AURINIA PHARMACEUTICALS INC (AUPH) · IMMATICS N.V (IMTX) · RECURSION PHARMACEUTICALS IN (RXRX) · CAPRICOR THERAPEUTICS INC (CAPR)